BEAT CF: Pulmonary Exacerbations Treatment Platform - Backbone Antibiotics Domai

Not Applicable

Recruiting

• Conditions: Cystic Fibrosis; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12622000950763
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-05
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

1. Be enrolled in the BEAT CF PEx Cohort (ACTRN12621000638831).
2. Documented informed consent to participate in the Backbone antibiotics Domain.
3. Are eligible for at least two Interventions in the Backbone Antibiotic Domain available at the clinical Site.
4. Must be able to reliably perform spirometry.

Exclusion Criteria

1. The person is unable to reliably perform spirometry (for example due to young age)
2. The person’s Responsible Clinician deems enrolment in the PEx Backbone Antibiotic Domain is not in their best interest.
A participant will be excluded from Assignment to a specific Intervention in the Backbone Antibiotics Domain if:
1. They have a known or suspected significant drug hypersensitivity to that antibiotic
2. They have another recognised contraindication to that antibiotic
3. The Intervention is deemed unacceptable by the Responsible Clinician e.g. because of a poor treatment response to that antibiotic (requiring a change in antibiotic treatment) in the preceding 12 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified